CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies

VIENNA — New data reported here reinforce the idea that chimeric antigen receptor T-cell (CAR-T) therapy can be an out-and-out cure for many rheumatologic diseases.

Penbraya is the first and only vaccine that covers all five serogroups approved for meningococcal disease. Credit: Vadym Terelyuk via Getty Images. The US Food